MajhailNSRizzoJDLeeSJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012;18(3):348-371.
2.
AcunaSAHuangJWScottAL, et al. Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines. Am J Transplant. 2017;17(1):103-114.
3.
WuPASternRSHuangV, et al. Reduced-intensity conditioning regimens, prior chronic lymphocytic leukemia, and graft-versus-host disease are associated with higher rates of skin cancer after allogeneic hematopoietic stem cell transplantation. J Invest Dermatol. 2019;139(3):591-599.
4.
OmlandSHGniadeckiRHædersdalMHelweg-LarsenJOmlandLH.Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study. JAMA Dermatol2016;152(2):177-183.
5.
GarrettGLBlancPDBoscardinJ, et al. Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatol. 2017;153(3):296-303.
6.
HarteveltMMBavinckJNKootteAM, et al. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation1990;49(3):506-509.
